Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis
- 29 September 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 137 (5), 887-896
- https://doi.org/10.1007/s00432-010-0951-3
Abstract
To summarize the global predicting role of systemic inflammatory response for survival in renal cell carcinoma. Eligible studies were identified and assessed for quality through multiple search strategies. Data were collected from studies comparing overall, cancer-specific or relapse-free survival in patients with elevated C-reactive protein (CRP), platelet count (PC) and erythrocyte sedimentation rate (ESR) levels with those with lower levels. Studies were pooled, and combined hazard ratios (HRs) of CRP, PC and ESR for survival were calculated, respectively. A total of 47 studies were included for meta-analysis (18 for CRP, 15 for PC and 14 for ESR). For overall survival, the pooled HR of CRP (3.23, 95% CI: 1.77, 5.89) was higher than that of PC (1.96, 95% CI: 1.40, 2.75) and that of ESR (1.86, 95% CI: 1.34, 2.59). These indicators were strong predictors for cancer-specific survival with individual HRs being 3.46 (95% CI, 2.80, 4.27) of CRP, 3.22 (95% CI, 2.25, 4.62) of PC, and 3.85 (95% CI, 3.31, 4.48) of ESR, respectively. All three inflammatory indictors also predicted relapse-free survival (HRs > 2.0). The systemic inflammatory response predicted poor survival in patients with renal cell carcinoma.Keywords
This publication has 52 references indexed in Scilit:
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancerFuture Oncology, 2010
- Inflammation and cancer: how friendly is the relationship for cancer patients?Current Opinion in Pharmacology, 2009
- The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomyBMC Urology, 2008
- Association of Abnormal Preoperative Laboratory Values with Survival After Radical Nephrectomy for Clinically Confined Clear Cell Renal Cell CarcinomaUrology, 2008
- A Comprehensive Prognostic Stratification for Patients with Metastatic Renal Clear Cell CarcinomaYonsei Medical Journal, 2008
- Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancerCancer, 2007
- Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variableBritish Journal of Cancer, 2006
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Inflammation and cancerNature, 2002
- Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-αEuropean Journal of Cancer, 1994